Free Trial

Medpace (MEDP) Competitors

Medpace logo
$321.50 -4.53 (-1.39%)
Closing price 07/3/2025 02:02 PM Eastern
Extended Trading
$321.18 -0.32 (-0.10%)
As of 07/3/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MEDP vs. ICLR, EHC, ELV, HIMS, IQV, RDDT, GIB, CPAY, TOST, and AER

Should you be buying Medpace stock or one of its competitors? The main competitors of Medpace include Icon (ICLR), Encompass Health (EHC), Elevance Health (ELV), Hims & Hers Health (HIMS), IQVIA (IQV), Reddit (RDDT), CGI Group (GIB), Corpay (CPAY), Toast (TOST), and Aercap (AER).

Medpace vs. Its Competitors

Medpace (NASDAQ:MEDP) and Icon (NASDAQ:ICLR) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment.

78.0% of Medpace shares are owned by institutional investors. Comparatively, 95.6% of Icon shares are owned by institutional investors. 20.3% of Medpace shares are owned by company insiders. Comparatively, 44.0% of Icon shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Medpace had 2 more articles in the media than Icon. MarketBeat recorded 6 mentions for Medpace and 4 mentions for Icon. Medpace's average media sentiment score of 0.88 beat Icon's score of 0.26 indicating that Medpace is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medpace
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Icon
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Medpace has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500. Comparatively, Icon has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500.

Icon has higher revenue and earnings than Medpace. Icon is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medpace$2.11B4.38$404.39M$13.1024.54
Icon$8.28B1.46$791.47M$9.1816.35

Medpace has a net margin of 19.31% compared to Icon's net margin of 9.25%. Medpace's return on equity of 54.36% beat Icon's return on equity.

Company Net Margins Return on Equity Return on Assets
Medpace19.31% 54.36% 20.81%
Icon 9.25%11.46%6.49%

Medpace presently has a consensus target price of $344.82, suggesting a potential upside of 7.25%. Icon has a consensus target price of $213.08, suggesting a potential upside of 42.00%. Given Icon's stronger consensus rating and higher probable upside, analysts plainly believe Icon is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medpace
0 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.21
Icon
0 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.60

Summary

Medpace beats Icon on 9 of the 17 factors compared between the two stocks.

Get Medpace News Delivered to You Automatically

Sign up to receive the latest news and ratings for MEDP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MEDP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MEDP vs. The Competition

MetricMedpaceMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$9.24B$7.31B$5.56B$9.04B
Dividend YieldN/A2.78%5.24%4.01%
P/E Ratio24.5427.9427.6120.24
Price / Sales4.3832.39417.30118.22
Price / Cash23.0422.0136.8958.10
Price / Book12.106.698.035.67
Net Income$404.39M$233.06M$3.18B$249.21M
7 Day Performance3.48%3.33%2.93%3.28%
1 Month Performance9.51%3.72%3.75%5.55%
1 Year Performance-20.10%37.40%35.20%21.09%

Medpace Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MEDP
Medpace
4.4545 of 5 stars
$321.50
-1.4%
$344.82
+7.3%
-20.2%$9.24B$2.11B24.545,900
ICLR
Icon
4.3687 of 5 stars
$145.45
+0.6%
$213.08
+46.5%
-52.8%$11.75B$8.28B15.8441,900
EHC
Encompass Health
4.8537 of 5 stars
$122.60
+0.3%
$127.00
+3.6%
+38.4%$12.36B$5.37B25.3340,000News Coverage
Positive News
Ex-Dividend
ELV
Elevance Health
4.9709 of 5 stars
$389.42
+2.1%
$498.87
+28.1%
-34.2%$87.98B$183.12B15.19102,300
HIMS
Hims & Hers Health
2.1767 of 5 stars
$49.94
+1.1%
$39.58
-20.7%
+133.8%$11.18B$1.48B72.381,637Trending News
Insider Trade
IQV
IQVIA
4.8453 of 5 stars
$157.69
+0.1%
$226.32
+43.5%
-20.6%$27.28B$15.41B21.4886,000
RDDT
Reddit
2.3034 of 5 stars
$150.74
+5.4%
$139.57
-7.4%
+113.7%$27.81B$1.30B255.502,233Trending News
Analyst Forecast
Insider Trade
GIB
CGI Group
3.8925 of 5 stars
$104.93
+1.5%
$156.75
+49.4%
+3.9%$23.55B$10.79B19.1190,000Positive News
CPAY
Corpay
3.9286 of 5 stars
$332.07
+1.5%
$401.86
+21.0%
+26.8%$23.41B$3.97B23.2910,500Positive News
TOST
Toast
2.7429 of 5 stars
$44.33
+1.0%
$41.21
-7.0%
+72.2%$22.08B$4.96B192.744,500Positive News
Analyst Downgrade
AER
Aercap
2.5356 of 5 stars
$116.96
-0.2%
$119.25
+2.0%
+23.4%$21.85B$8.06B10.38740Gap Up

Related Companies and Tools


This page (NASDAQ:MEDP) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners